Quarterly Flipbook: Earnings growth and downgrade cycle bottoming-out
The aggregate performance of the Q1FY26 earnings season was steady as sequential improvement in YoY PAT growth continued in the current quarter
295 Views
APAC Healthcare Weekly (Aug 24) – Wuxi Bio, Ab&B Bio, Ascletis Pharma, Remegen, Daiichi Sankyo, CSL
Wuxi Bio got EMA nod for Ireland manufacturing facility. Daiichi Sankyo got breakthrough therapy designation for its drug candidate in US. CSL...
698 Views
APAC Healthcare Weekly (Aug 17) – Fosun Pharma, Remegen, Astellas, Daewoong Pharma, Zydus, Lupin
Astellas, Remegen, and Daewoong Pharma announced positive trial results for their respective drug candidates. Fosun Pharma stuck outlicensing deal....
966 Views
Pharmaceuticals: IPM: 7% value and 2% unit decline in Jul-25
As per IQVIA, IPM saw 7.1% YoY growth in Jul-25 on a high base of 11.7% growth in Jul-24 (~11.5% YoY in Jun’25, 9% YoY in Q1FY26, and 8% in FY25)...
216 Views
HSIE Results Daily: Bajaj Auto, Trent, Lupin, Prestige Estates, Berger Paints...
Bajaj Auto: The company continues to face headwinds in its key export market, NigeriaWhile currency tailwinds should aid the rest of the exports,...
283 Views